PUBLISHER: Zhar Research | PRODUCT CODE: 1927577
PUBLISHER: Zhar Research | PRODUCT CODE: 1927577
Terahertz was the medical Wild West. The Terahertz Gap at 0.1-10THz was where neither radio frequency nor optical components worked well and the benefits were unclear. Now it is more like a gold rush, with new materials such as graphene in plasmonic mode working best at those frequencies. Other 2D materials, tertiary 3-5 compounds, co-polymers and more are in hot pursuit. Resulting sensors, imagers, spectrometers and even radiation therapy equipment are being deployed into over 200,000 hospitals and medical research centers and pharmaceutical production lines worldwide 2026-2046. Medical and allied THz equipment sales will grow over eleven-fold over that timeframe to $8.8 billion in 2046. There is upside potential on this forecast if the identified challenges are overcome.
A new Zhar Research report details your opportunities. This 374-page, commercially-oriented, "Terahertz Medical Diagnosis, Therapy, Hardware, Materials: Markets, Technology 2026-2046".
Leading author Dr Peter Harrop, CEO of Zhar Research says, "Most importantly, using THz facilitates increasingly improves detection and treatment of cancers but there is much more in the pipeline, including the equipment becoming portable, its use in design and production of new pharmaceuticals and medical radioisotopes, dentistry and veterinary uses and previously-impossible diagnosis and therapy. To reveal all your opportunities, the report includes these closely allied topics."
Old news is misleading in this now fast-moving topic so the report is intensely focussed on the flood of research advances 2025-6 and gaps in the market given the rather limited number of THz equipment suppliers for what will be needed.
The Executive Summary and Conclusions (55 pages) is self-sufficient for those with limited time. See 11 SWOT appraisals 16 key conclusions, 21 forecast lines 2026-2046 with graphs and explanation plus the main infograms.